XEMC:CA:TSX-iShares MSCI Emerging Markets ex China Index ETF (CAD)

ETF | Others |

Last Closing

CAD 49.95

Change

-0.19 (-0.38)%

Market Cap

N/A

Volume

3.24K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-21 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

-0.32 (-1.13%)

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

N/A

CAD 5.47B
XEQT:CA iShares Core Equity Portfolio

-0.15 (-0.45%)

CAD 5.05B
PHYS-U:CA Sprott Physical Gold Trust

+0.05 (+0.24%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

-0.15 (-0.41%)

CAD 4.54B
HXT-U:CA Global X S&P/TSX 60 Index ETF

N/A

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

+0.16 (+0.62%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

+0.29 (+2.62%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

-0.15 (-0.66%)

CAD 2.78B
ZMMK:CA BMO Money Market Fund ETF Seri..

+0.01 (+0.02%)

CAD 2.57B

ETFs Containing XEMC:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 14.43% 58% F 56% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.43% 58% F 56% F
Trailing 12 Months  
Capital Gain 25.95% 61% D- 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 25.95% 61% D- 59% D-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 6.72% 77% C+ 60% D-
Dividend Return 6.72% 76% C+ 55% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.44% 51% F 76% C+
Risk Adjusted Return 79.65% 93% A 89% A-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike